Neuren Pharmaceuticals | NEU - Operating Expenses


Neuren Pharmaceuticals reported AUD25.23M in Operating Expenses for its fiscal semester ending in December of 2025.





Operating Expenses Change Date
Akebia Therapeutics USD 63.08M 8.26M Dec/2025
Alaunos Therapeutics USD 1.01M 175K Mar/2026
Avita Medical AUD 28.02M 1.55M Dec/2025
Clinuvel Pharmaceuticals AUD 23.42M 6.49M Dec/2025
Dianthus Therapeutics USD 47M 22.83M Mar/2026
Genetic Signatures AUD 17.52M 9.22M Dec/2025
Ionis Pharmaceuticals USD 370.24M 6.24M Jun/2026
Medical Developments International AUD 21.61M 11.59M Dec/2025
Neuren Pharmaceuticals AUD 25.23M 16.54M Dec/2025
Organon & Co USD 1.01B 103M Jun/2026
Paradigm Biopharmaceuticals AUD 21.85M 13.36M Dec/2025
PYC Therapeutics AUD 33.63M 14.33M Dec/2025
Starpharma Holdings AUD 11.7M 7.69M Dec/2025
Tectonic Therapeutic USD 27.3M 5.78M Mar/2026
Telix Pharmaceuticals AUD 430.99M 25.59M Jun/2026
Viatris USD 3.68B 145.9M Jun/2026
Xeris Pharmaceuticals USD 75.21M 6.18M Mar/2026